Benefits and Risks of Biologic and Nonbiologic DMARDs
Biologic and Nonbiologic DMARDs are effective treatments for rheumatoid arthritis. Biologic DMARDs target the specific molecules that cause inflammation in the body, while Nonbiologic DMARDs work by altering the body’s immune system to reduce inflammation.
The benefits of taking Biologic DMARDs for rheumatoid arthritis treatment include reducing inflammation, improving physical functioning, and reducing joint pain. They also reduce the need for additional medications, such as corticosteroids and nonsteroidal anti-inflammatory drugs. Potential risks associated with Biologic DMARDs include an increased risk of infection, increased risk of certain types of cancer, and an increased risk of developing other autoimmune diseases.
Nonbiologic DMARDs are generally less expensive than Biologic DMARDs and are generally the first-line treatments for rheumatoid arthritis. The benefits of Nonbiologic DMARDs include reducing fatigue and improving physical functioning. The potential risks associated with Nonbiologic DMARDs include gastrointestinal side effects, liver damage, and an increased risk of infections.
It’s important to discuss the potential benefits and risks of both Biologic and Nonbiologic DMARDs with your healthcare professional before starting any treatment.